title: FAME, a novel conditioning regimen for allogeneic stem cell transplantation for lymphoma, does not earn fame.
authors.forename: Masahiro
authors.initials: M
authors.lastname: Ashizawa
authors.forename: Shinichi
authors.initials: S
authors.lastname: Kako
authors.forename: Hidenori
authors.initials: H
authors.lastname: Wada
authors.forename: Kana
authors.initials: K
authors.lastname: Sakamoto
authors.forename: Miki
authors.initials: M
authors.lastname: Sato
authors.forename: Kiriko
authors.initials: K
authors.lastname: Terasako
authors.forename: Shun-ichi
authors.initials: S
authors.lastname: Kimura
authors.forename: Misato
authors.initials: M
authors.lastname: Kikuchi
authors.forename: Hideki
authors.initials: H
authors.lastname: Nakasone
authors.forename: Shinya
authors.initials: S
authors.lastname: Okuda
authors.forename: Rie
authors.initials: R
authors.lastname: Yamazaki
authors.forename: Kumi
authors.initials: K
authors.lastname: Oshima
authors.forename: Junji
authors.initials: J
authors.lastname: Nishida
authors.forename: Yoshinobu
authors.initials: Y
authors.lastname: Kanda
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003561:Cytarabine / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D008223:Lymphoma / Q000601:surgery / Q000628:therapy*; D008558:Melphalan / Q000008:administration & dosage; D008875:Middle Aged; D019172:Transplantation Conditioning / Q000379:methods*; D014184:Transplantation, Homologous / Q000379:methods; D014740:Vidarabine / Q000008:administration & dosage / Q000031:analogs & derivatives
chemical_list: D003561:Cytarabine; D005047:Etoposide; D014740:Vidarabine; C024352:fludarabine; D008558:Melphalan